Granules Pharmaceuticals - About the company
Granules Pharmaceuticals is an unfunded company based in Chantilly (United States), founded in 2014. It operates as a Pharmaceutical product manufacturing company. Granules Pharmaceuticals has not raised any funding yet.
Company Details
Granules Pharmaceuticals Inc. is a subsidiary of Granules India, located in Chantilly, Virginia. They focus on bringing cost-effective, high-quality pharmaceutical products to the market.
- Website
- granulespharma.com
- Registered Address
- 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, K.V.Rangareddy, Serilingampally, Telangana, India, 500084
Key Metrics
Founded Year
2014
Location
Chantilly, United States
Stage
Unfunded
Employee Count
522 as on Sep 30, 2026
Legal entities associated with Granules Pharmaceuticals
Granules Pharmaceuticals is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
GRANULES INDIA LIMITED CIN: L24110TG1991PLC012471 , India, Active | Mar 18, 1991 | ₹1,000+ Cr (As on Mar 31, 2026) | 4371 (As on May 01, 2026) | |
GRANULES PHARMACEUTICALS, INC. CIN: 472137127 , United States, Active | Dec 31, 1999 | - | 312 (As on Dec 31, 2024) | - |
Sign up to download Granules Pharmaceuticals' company profile
Granules Pharmaceuticals's funding and investors
Granules Pharmaceuticals has not raised any funding rounds yet.
Granules Pharmaceuticals' founders and board of directors
Founder? Claim ProfileGranules Pharmaceuticals' employee count trend
Granules Pharmaceuticals has 522 employees as of Sep 26. Here is Granules Pharmaceuticals's employee count trend over the years:
Uncover Granules Pharmaceuticals' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Granules Pharmaceuticals's Investments and acquisitions
Granules Pharmaceuticals has made no investments or acquisitions yet.
Reports related to Granules Pharmaceuticals
Here is the latest report on Granules Pharmaceuticals's geography:
News related to Granules Pharmaceuticals
Media has covered Granules Pharmaceuticals for 1 event in last 1 year.
•
Granules Pharmaceuticals Receives FDA Tentative Approval with 180-Day Exclusivity for gDYANAVEL XRIndiaMedToday•Jan 08, 2026•Granules Pharmaceuticals
•
Granules arm gets U.S. FDA observation resolvedThe Hindu•Jun 28, 2025•Granules India, Granules Pharmaceuticals
•
API maker Granules Pharma simplifies structure involving US subsidiariesMoneycontrol•Mar 25, 2025•Granules Pharmaceuticals, Fiercepharma
•
•
U.S. FDA gives nod for Granules copy of GlaxoSmithKline's AdvilThe Hindu•Jul 15, 2023•Granules Pharmaceuticals
•
Granules India receives USFDA approval for Losartan Potassium TabletsBusiness Standard•Feb 27, 2023•Granules Pharmaceuticals, Granules India, Organon
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Granules Pharmaceuticals
Explore our recently published companies
- Faversham Quarters - United Kingdom based, Unfunded company
- Siri Salon - Thailand based, Unfunded company
- Coastline Landscaping - Unfunded company
- Solwey - Austin based, 2016 founded, Unfunded company
- ContrivaPro - Unfunded company
- Shardae Writes - Washington based, Unfunded company
